Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU

As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered. Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.

Participants needed: 34
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Emre ŞenocakUpdated: Nov 25, 2025Locations: 1
Eligibility criteria

Aged 18-85, [+5]

Patients whose GCS fell to 14 or below for any reason during the study period; [+9]

Status: Recruiting

Kinesiophobia Scale for the Upper Extremity

Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems. The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.

Participants needed: 150
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Emre ŞenocakUpdated: Nov 19, 2025Locations: 2
Eligibility criteria

Tampa Kinesiophobia Score >37 points [+2]

Malignancy, [+4]

Status: Recruiting

Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities

The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools; * Measurement of median nerve thickness with ultrasound * Electromyography * Visual Analog Scale * Short Form-36 Evaluations will be made twice by a specialist physician before and after the treatments.

Participants needed: 60
Trial details
Age: 30-60Biological sex: AllType: InterventionalSponsor: Emre ŞenocakUpdated: Sep 11, 2025Locations: 1
Eligibility criteria

Individuals between the ages of 30-60 who have been diagnosed with CTS by a spec... [+4]

Presence of atrophy in the thenar muscles, [+5]

Status: Recruiting

Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients

Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.

Participants needed: 34
Trial details
Age: 45-75Biological sex: AllType: ObservationalSponsor: Emre ŞenocakUpdated: Mar 7, 2025Locations: 1Duration: 2 Days
Eligibility criteria

Hoehn & Yahr staging ≤3 points, [+2]

Those with severe heart disease such as heart failure, cardiac arrhythmia, hyper... [+5]

Status: Recruiting

Minimal Clinically Important Difference of the Box and Block Test in Parkinson

The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful. Patients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist. Upper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.

Participants needed: 44
Trial details
Age: 50-80Biological sex: AllType: InterventionalSponsor: Emre ŞenocakUpdated: Mar 5, 2025Locations: 1
Eligibility criteria

Being Hoehn & Yahr Stage between 1-3, [+2]

Mini-mental status assessment < 24 points; [+6]

Status: Recruiting

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.

Participants needed: 39
Trial details
Age: 40-80Biological sex: AllType: ObservationalSponsor: Emre ŞenocakUpdated: Mar 5, 2025Locations: 1Duration: 30 Days
Eligibility criteria

Having regular neurology follow-up and using medicine; [+2]

Having a secondary neurological disease; [+6]